Saturday May 18, 2024 | Last Update: May 18, 2024 EDT
Actavis is trying its best to finish the deal with Allergan and plans to pay more than $210 per share, or over $62 billion for the pharmaceutical company—higher than their previous offer.
Read more >>
Allergan Inc Set to Buy Salix Phamaceuticals
Just In
Most Read
1
2
3
4
5